Cargando…
Intradiscal Autologous Platelet-Rich Plasma Injection for Discogenic Low Back Pain: A Clinical Trial
BACKGROUND: Platelet-rich plasma (PRP) contains high concentrations of growth factors and cytokines and may promote healing and tissue formation and exert anti-inflammatory effects. PRP has been shown to improve intervertebral disc degeneration in vivo and in vitro. This study is aimed at evaluating...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576382/ https://www.ncbi.nlm.nih.gov/pubmed/36262971 http://dx.doi.org/10.1155/2022/9563693 |
_version_ | 1784811513356222464 |
---|---|
author | Zhang, Jianbo Liu, Dongyang Gong, Qingjuan Chen, Jinsheng Wan, Li |
author_facet | Zhang, Jianbo Liu, Dongyang Gong, Qingjuan Chen, Jinsheng Wan, Li |
author_sort | Zhang, Jianbo |
collection | PubMed |
description | BACKGROUND: Platelet-rich plasma (PRP) contains high concentrations of growth factors and cytokines and may promote healing and tissue formation and exert anti-inflammatory effects. PRP has been shown to improve intervertebral disc degeneration in vivo and in vitro. This study is aimed at evaluating the effectiveness of autologous PRP on discogenic low back pain (DLBP) at 48 weeks postinjection in patients who received a single intradiscal injection. METHODS: All patients received a single intradiscal injection of PRP in a prospective trial. The pain scores, lumbar function, and adverse events were assessed at 1 week, 4 weeks, 8 weeks, 12 weeks, 24 weeks, and 48 weeks postinjection and compared to the preinjection values (0 weeks). RESULTS: Data were analysed from 31 patients with a 94% follow-up rate. Compared to preinjection, pain and lumbar function were significantly improved, and there were significant differences (P < 0.05) over the 48-week follow-up. Twenty-two (71%) patients were classified as successes after the intradiscal injection of PRP. One patient received surgery at two weeks postinjection due to intervertebral discitis. CONCLUSIONS: Intradiscal injection of PRP can significantly relieve pain sensation and improve lumbar function in patients with DLBP over a 48-week follow-up period. Further randomized controlled clinical trials are needed to assess the effects of this injection therapy. |
format | Online Article Text |
id | pubmed-9576382 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-95763822022-10-18 Intradiscal Autologous Platelet-Rich Plasma Injection for Discogenic Low Back Pain: A Clinical Trial Zhang, Jianbo Liu, Dongyang Gong, Qingjuan Chen, Jinsheng Wan, Li Biomed Res Int Research Article BACKGROUND: Platelet-rich plasma (PRP) contains high concentrations of growth factors and cytokines and may promote healing and tissue formation and exert anti-inflammatory effects. PRP has been shown to improve intervertebral disc degeneration in vivo and in vitro. This study is aimed at evaluating the effectiveness of autologous PRP on discogenic low back pain (DLBP) at 48 weeks postinjection in patients who received a single intradiscal injection. METHODS: All patients received a single intradiscal injection of PRP in a prospective trial. The pain scores, lumbar function, and adverse events were assessed at 1 week, 4 weeks, 8 weeks, 12 weeks, 24 weeks, and 48 weeks postinjection and compared to the preinjection values (0 weeks). RESULTS: Data were analysed from 31 patients with a 94% follow-up rate. Compared to preinjection, pain and lumbar function were significantly improved, and there were significant differences (P < 0.05) over the 48-week follow-up. Twenty-two (71%) patients were classified as successes after the intradiscal injection of PRP. One patient received surgery at two weeks postinjection due to intervertebral discitis. CONCLUSIONS: Intradiscal injection of PRP can significantly relieve pain sensation and improve lumbar function in patients with DLBP over a 48-week follow-up period. Further randomized controlled clinical trials are needed to assess the effects of this injection therapy. Hindawi 2022-10-10 /pmc/articles/PMC9576382/ /pubmed/36262971 http://dx.doi.org/10.1155/2022/9563693 Text en Copyright © 2022 Jianbo Zhang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Zhang, Jianbo Liu, Dongyang Gong, Qingjuan Chen, Jinsheng Wan, Li Intradiscal Autologous Platelet-Rich Plasma Injection for Discogenic Low Back Pain: A Clinical Trial |
title | Intradiscal Autologous Platelet-Rich Plasma Injection for Discogenic Low Back Pain: A Clinical Trial |
title_full | Intradiscal Autologous Platelet-Rich Plasma Injection for Discogenic Low Back Pain: A Clinical Trial |
title_fullStr | Intradiscal Autologous Platelet-Rich Plasma Injection for Discogenic Low Back Pain: A Clinical Trial |
title_full_unstemmed | Intradiscal Autologous Platelet-Rich Plasma Injection for Discogenic Low Back Pain: A Clinical Trial |
title_short | Intradiscal Autologous Platelet-Rich Plasma Injection for Discogenic Low Back Pain: A Clinical Trial |
title_sort | intradiscal autologous platelet-rich plasma injection for discogenic low back pain: a clinical trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576382/ https://www.ncbi.nlm.nih.gov/pubmed/36262971 http://dx.doi.org/10.1155/2022/9563693 |
work_keys_str_mv | AT zhangjianbo intradiscalautologousplateletrichplasmainjectionfordiscogeniclowbackpainaclinicaltrial AT liudongyang intradiscalautologousplateletrichplasmainjectionfordiscogeniclowbackpainaclinicaltrial AT gongqingjuan intradiscalautologousplateletrichplasmainjectionfordiscogeniclowbackpainaclinicaltrial AT chenjinsheng intradiscalautologousplateletrichplasmainjectionfordiscogeniclowbackpainaclinicaltrial AT wanli intradiscalautologousplateletrichplasmainjectionfordiscogeniclowbackpainaclinicaltrial |